There were a number of stocks which had emerged as notable gainers on Thursday and one of those was the Enzolytics Inc (OTCMKTS:ENZC) stock. The company’s stock was in the middle of a mini rally and ended the day with gains of as much as 4%.
On Thursday, ENZC stock gained 4% to $0.0845 with 4.01 million shares, compared to its average volume of 14.15 million shares. The stock moved within a range of $0.0805 – 0.0885 after opening trade at $0.0885.
Enzolytics IPF Immune(TM), an Immune Modulator, Is Introduced into the U.S. Market This Month
In this context, it is important for investors to note that on Thursday the company had announced that its immune modulating product Enzolytics IPF Immune would be launched in the United States market later on in March. The product in question is going to be presented later on this month by Nutritional Products International, which is Enzolytics’ representative.
The presentation is going to be made to small as well as large retailers who are going to be present at the Weight Management, Nutrition, and Vitamin Convention that is going to be hosted by ECRM.
More importantly, it will be possible for the product to be showcased to some of the biggest retailers in the industry like Amazon, Walgreens, CVS Health and GNC among others. It can be said that the event could eventually lead to a considerable boost for Enzolytics if it can bag a few orders.
ENZC stock is trading above the 20-Day and 50-Day Moving averages of $0.0866 and $0.0944 respectively. Moreover, the stock is trading is the neutral zone with RSI stands at 46.